XtalPi Partners with Visen Pharma to Accelerate AI‑Driven Endocrine Drug Discovery
CompanyDeals

XtalPi Partners with Visen Pharma to Accelerate AI‑Driven Endocrine Drug Discovery

Policy / Regulatory

China’s NHSA Opens NRDL to AI and Digital Health Innovation, Unveils Scenario‑Driven Reimbursement Reform

J&J Darzalex Faspro Gets NMPA Approval for Transplant-Eligible Myeloma Patients
CompanyDrug

J&J Darzalex Faspro Gets NMPA Approval for Transplant-Eligible Myeloma Patients

Shanghai Pharma to Divest 30% Stake in Sino-American Squibb for $147M
CompanyDeals

Shanghai Pharma to Divest 30% Stake in Sino-American Squibb for $147M

Everest Medicines Files Velsipity for Ulcerative Colitis in China
CompanyDrug

Everest Medicines Files Velsipity for Ulcerative Colitis in China

Bristol-Myers Squibb Growth Portfolio Drives 17% Revenue Increase in 2025
Company

Bristol-Myers Squibb Growth Portfolio Drives 17% Revenue Increase in 2025

Keytruda Wins 20th China Approval for Endometrial Cancer in First-Line Setting
CompanyDrug

Keytruda Wins 20th China Approval for Endometrial Cancer in First-Line Setting

Policy / Regulatory

Give Kids a Chance Act Extends FDA Pediatric Research Authority and PRV Program

Eli Lilly Revenue Surges 45% to $65.2B on Incretin Portfolio Strength
Company

Eli Lilly Revenue Surges 45% to $65.2B on Incretin Portfolio Strength

Novartis Revenue Growth Hits 8% Despite Entresto and Promacta Generic Erosion
Company

Novartis Revenue Growth Hits 8% Despite Entresto and Promacta Generic Erosion

CompanyDeals

Everest Medicines Licenses Micot’s MT1013 for Secondary Hyperparathyroidism in $178M Deal

GE HealthCare Revenue Grows 5% to $20.6B on Imaging and Diagnostics Strength
CompanyMedical Device

GE HealthCare Revenue Grows 5% to $20.6B on Imaging and Diagnostics Strength